Tiziana Life Sciences PLC Share Price London S.E.
Equities
GB00B28XMY25
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- GBX | - |
Sales 2022 | - | Sales 2023 | - | Capitalization | 5.62Cr 468.55Cr |
---|---|---|---|---|---|
Net income 2022 | -1.5Cr -125.12Cr | Net income 2023 | -1.7Cr -141.8Cr | EV / Sales 2022 | - |
Net cash position 2022 | 1.78Cr 148.11Cr | Net cash position 2023 | 9L 7.81Cr | EV / Sales 2023 | - |
P/E ratio 2022 |
-3.95
x | P/E ratio 2023 |
-3.29
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 32.75% |
Latest transcript on Tiziana Life Sciences PLC
Managers | Title | Age | Since |
---|---|---|---|
Gabriele Cerrone
CEO | Chief Executive Officer | 52 | 11/98/11 |
Keeren Shah
DFI | Director of Finance/CFO | 47 | - |
Vaseem Palejwala
CTO | Chief Tech/Sci/R&D Officer | - | 01/17/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Brancaccio
BRD | Director/Board Member | 76 | 01/20/01 |
Willy Simon
BRD | Director/Board Member | 72 | 01/15/01 |
Gabriele Cerrone
CEO | Chief Executive Officer | 52 | 11/98/11 |
1st Jan change | Capi. | |
---|---|---|
+43.36% | 5.81TCr | |
-5.31% | 4.05TCr | |
+37.52% | 3.9TCr | |
+14.75% | 2.67TCr | |
-12.56% | 2.66TCr | |
-22.45% | 1.9TCr | |
+0.04% | 1.22TCr | |
+25.12% | 1.2TCr | |
+26.04% | 1.19TCr |